# Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-12 08:29 UTC · Category: Health · Sources: 8 · Current Velocity: 5.66

## Intelligence Brief
"Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk" developed substantial multi-source reporting across the Health sector, tracked across 8 distinct newsrooms by Newsylist.


Key reporting was led by Inside Precision Medicine, tum.de, TCTMD.com and News-Medical. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk?
Coverage spiked when 8 independent newsrooms published 8 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Inside Precision Medicine | MACE Risk May Be Reduced with GLP-1 Drug in High-Risk Patients | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxNVEdJYVVwMFNINkRab1pSTENsNUs3c3M2YmQ1LURlMkVaZ0NMRGdkdmhZbDV6SjU4ejFxQ2lrdGo1QURwU3RUMzcwcmVmd3RQWTFXZnUxTjR6dkViWUx5UUs0WFd6b1JQeGExTTMwTEVWQUJ2ajVnb0k2cDd3MlE0TVpOUm1BbjBTQWprZTM2UGxhYk1iaVFmbTl5RF9tb2Ztc251WmRrT05qUjVFUFVuaWVuYmVySmowY0loQXpnUXRFTkdrZkk3YQ?oc=5) |
| tum.de | Obesity drug significantly reduces the risk of serious cardiovascular events and infections | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMi8wFBVV95cUxNanpNODZrZ3A4ZGFHalJRRVVUcHMtMHFsY0NlbWZYaDQ5RkRneVpUZXU1NlVpU2Fnd0luVnpoVTJIaXRHeU5ucVNWU2tsM0FhOXVrMkFnaWtTOGhaVDh3NVdUTG1vZHlMWUpCVUd5ZUxLb0hhamhJTGhHc3VKTlJFRkJjWUpPWmxKLTdBUU5aZnBZMkFsNFpMdjFxSmFsT2Q3bEdaVGw1NDB0R2x5N3dtZVRlaTB6Z011Q19uNG1vbTg5TFNqOFAwM1Z2Qmw3RXFXY09STUtPTkNKSmtyXy15MVBmQ21GSUdBbWZoemhVNHNRRXM?oc=5) |
| TCTMD.com | Claims Data Lend Support to Tirzepatide’s CV Effects in Patients With Diabetes | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxPbmxpMmliaTJ0WUJCaW01Nzl2SVhZZThfWW9idUZ1T0ZQb05rSGhUXzRyOV84UWdOdVNyYTlvdW03d0lnRXVQOUtfZVVhaS1PcTZGMU1OVjFqZ3JtejV1eHp3ekpGTjNjazhFZ0VrcFFmeE9kNEtsVlRKaEsxZ0V1Sm5TcmZQVjhWNVFUWE9xel9RRTVRck53cg?oc=5) |
| News-Medical | Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetes | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxNUlhJZ05wQmZoMFJ0WjNwb3pTbUVQcWxZcWdGUGV5SkdvTG9aUmJqUUVLZ0g2anAweG42M0otUS0yMmtFRl9MMEpXWnVtZGNRVWFyQ3V4RTh2cjFaMDRkYUl1Y2h5UjdWaV9ZYi1CY29tazNBYVpOaWllNmlsUkl0bnVaRWNBNGlwaHhMTmZWaUhDeEo5WGt6Z0x4a3dkVERyUFJqTlJFVkx0SlRZaTJZRWR5dUxhMkprVkZsSTJCZUFRTGd2bkJQTUZYYXhIeGQwaUl5YXV6dw?oc=5) |
| U.S. News & World Report | Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxONkxXNzBIcDFOTWItRzhHZUhEaFJ2NzVDam5qS1Q2WU1nRUp6T2l2TzhwOTZ6SVA5ZHlrbG94a0NSRXJXdlBUVUZqZGtYM0pSTGJuUTNicE1sZlVqZkFuMS1XdW9UNGpIRjBJZXBPNnRnbEhsU2U5bU9mb1k0RFNQUGVZc3RYdXhVcm92Q2JFNG5rSF9rOXluSXY5clpoWUk3RVVaTm9mODR6WWNkbnFxZnpUT2o3bllJczhzakJlMEk?oc=5) |
| Deutsches Zentrum für Herz-Kreislauf-Forschung | Obesity drug significantly reduces the risk of serious cardiovascular events and infections | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMi7wFBVV95cUxOaTQ1WEJrMF9mOWxKOWwtQ3pRdkdXd1lKU1VpQWVBa1loM0lkWVZyR3Z3MHVkOWZmRWo3VjBaWmtKMFRsbW5LYTBnSkFHUXF1eERMQndSbk1GTWphM1dDaUU3MnNTVXFtM0ZXZ2lZdlhCV21SM0hKMXFoTFphWVFob05JaEpjY1dKOE9ldWZpWm1hRFlCdjVUWHJsMEFGN0x6VGlqbjB0czZLTUE0YXNzeV9MWnlqTU90clVQN2l6Tl9saU1XaERybnluZ3M2OUZieXNoZjIwaDRhZDBQb0NrRkhQMnpFWjl6bUZiUXltZw?oc=5) |
| Medical News Today | GLP-1 drugs like Mounjaro may help lower heart attack risk by 33% | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQjRDX1hwU3BhTzByS3JsZHFnY2E4V1VEd1VtYVNqSkd2N2x0eWpqYVFJSlRaZ1VrNU8ydm5ZSzlCX3VjRF9VT0hBOVRzZmhOUndXbk9rQ25tVUZ4Tk8xbEkteFZfMWxuQkI4YU9vUDhJTldFQk9vZjFKQkUyaHp6X3RDYzFybTNEZFY4Vm9sdE9uOEtaeUp5b0JHZEljY0VDR0d1V2NYVFpHRUk?oc=5) |
| Healthline | Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk | 2026-08-11 19:01 | [Source Link](https://news.google.com/rss/articles/CBMigwFBVV95cUxNcVh4VEVxbHFWbXF2ck9odWdMNzEzYnhkUzhlV2FJTVVNNUowcGliUS1BVlRjVERnSXRDMUsxQ3FCQWZMZVBsZzE2TjEyMW5JWnhXV0RGN0RMaFJMS2JpUzlsaGNpRnN5VzRyeUhJVmdqTE81M01ndU51NVBMalhYMWt2Yw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-12/type-2-diabetes-glp-1-mounjaro-may-lower-heart-attack-risk*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*